Answers are grounded in this paper and cite their sources.
Shows enhanced tumor penetration and catalytic therapy with NIR-powered nanorockets, suggesting improved treatment outcomes.
Nanozyme‐based nanomotors have shown significant potential in biomedical applications, particularly in catalytic tumor therapy, due to their stability and autonomous propulsion capabilities. However, their therapeutic efficacy is limited by diffusion barriers within dense tumor tissues and low catalytic efficiency in the mild tumor microenvironment. Herein, Ag 2 S‐decorated mesoporous silica‐coated CeVO 4 ‐based near‐infrared‐powered nanorockets were designed and synthesized for enhanced‐penetrating synergistic photothermal‐catalytic tumor therapy. In this construct, the CeVO 4 core acts as a redox‐active chemical engine within the permeable silica shell, facilitating glutathione depletion and reactive oxygen species (ROS) generation from endogenous H 2 O 2 . The anchored Ag 2 S nanoparticles endow the nanorockets with the capability of NIR‐driven self‐propulsion behavior via active thermophoresis. Under NIR irradiation, the localized heat drives the nanorockets to overcome diffusion barriers and reach internal tumor reservoirs. Simultaneously, this thermal effect accelerates catalytic reaction kinetics, thereby establishing a self‐sustaining therapeutic loop. This approach addresses the limitations of poor tissue penetration and low functional coupling, providing a motility‐enhanced, self‐amplifying anti‐tumor strategy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: